Will Speciality and GLP-1 Drugs Help COR Beat Q2 Earnings Estimates?

Cencora (COR) is slated to report second-quarter fiscal 2025 results on May 7, before market open. In the last reported quarter, the company delivered an earnings surprise of 6.57%. COR's earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 4.94%.(Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.) Q2 Estimates The Zacks Consensus Estimate for revenues is pegged at $74.82 billion, up 9.4% from the prior-year quarter's level. The consensus ma ...